China Ginsenoside Rd 52705-93-8, Find details about China Ginseng P. E, Ginsenoside RO from China Ginsenoside Rd 52705-93-8
Alias : 2-o-beta-d-glucopyranosyl-(3beta,12beta)-20-(beta-d-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-d-glucopyranoside
Ginsenoside Rd is a protopanaxadiol which has diverse in vitro and in vivo effects, including cardioprotective, neuroprotective, and anti-inflammatory actions.
Weight | Price | Stock |
---|---|---|
20mg | 21.90$ | In Stock |
50mg | 61.90$ | In Stock |
100mg | 124.90$ | In Stock |
>500mg | Get quote | In Stock |
IC50 Value & Target:
In Vitro: Have no relevant experimental datas.
In Vivo: Have no relevant experimental datas.
M.Wt | 947.15 |
---|---|
Formula | C48H82O18 |
CAS No. | 52705-93-8 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : 20-((6-o-alpha-l-arabinofuranosyl-beta-d-glucopyranosyl)oxy)-12b-hydroxydammar-24-en-3b-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Rc is a steroid glycoside, and triterpene saponins, found exclusively in the plant genus Panax (ginseng); have properties that inhibit or prevent tumors growth.
Weight | Price | Stock |
---|---|---|
20mg | 32.60$ | In Stock |
50mg | 85.60$ | In Stock |
100mg | 169.60$ | In Stock |
>500mg | Get quote | In Stock |
IC50 Value & Target:
In vitro: Rc reduced the proliferation and viability of 3T3-L1 preadipocytes in a dose-dependent manner. Treatment with Rc decreased the number of adipocytes and reduced lipid accumulation in maturing 3T3-L1 preadipocytes, demonstrating an inhibitory effect on lipogenesis. Rc directly induced lipolysis in adipocytes and down-regulated the expression of major transcription factors of the adipogenesis pathway, such as PPARγ and C/EBPα [1]. Overexpression of catalase induced by Rc resulted in suppression of RS production in kidney human embryo kidney 293T cells (HEK293T) cells, and that oxidative stress induced activation of PI3K/Akt and inhibition of the AMPK pathway and FoxO1 phosphorylation, leading to down-regulation of catalase, a FoxO1-targeting gene. In addition, treatment of HEK293T cells with Rc resulted in cAMP-response element-binding protein (CREB)-binding protein (CBP) regulated FoxO1 acetylation [2].
In Vivo: Have no relevant experimental datas.
M.Wt | 1079.27 |
---|---|
Formula | C53H90O22 |
CAS No. | 11021-14-0 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : 3-O-[β-D- glucopyranosyl-(1→2)-β-D-glucopyranosyl]-20-O-[β-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl]-dammar-24-ene-3β,12β,20S-triol
Ginsenoside Rb3 is a natural triterpenoid saponin; has various pharmacological effects.
Weight | Price | Stock |
---|---|---|
20mg | 42.80$ | In Stock |
50mg | 109.80$ | In Stock |
100mg | 204.80$ | In Stock |
>500mg | Get quote | In Stock |
How to purchase?
IC50 Value & Target:
In Vitro: Ginsenoside Rb3 suppresses OGD-Rep-induced cell apoptosis by the suppression of ROS generation. Ginsenoside Rb3 inhibits the upregulation of phospho-IκB-α and nuclear translocation of NF-κB subunit p65 which are induced by ORD-Rep injury. In addition, the extract also inhibits the OGD-Rep-induced increase in the expression of inflammation-related factors, such as IL-6, TNF-α, monocyte chemotactic protein-1 (MCP-1), MMP-2 and MMP-9 [1]. Ginsenoside Rb3 decreased cell cycle progression from G(0)/G(1) to S phase. Furthermore, ginsenoside Rb3 significantly attenuated the expression of mRNA of proto-oncogene c-myc, c-fos and c-jun [2]. Ginsenoside Rb3 (0.1-10 micromol/L) significantly increased cell viability and inhibited LDH release in a dose-dependent manner on the ischemic model. In addition, ginsenoside Rb3 also significantly inhibited ischemic injury-induced apoptosis, [Ca(2+)](i) elevation, and decrease of MMP [3].
In Vivo: Ex vivo treatment with Rb3 concentration-dependently augmented endothelium -dependent relaxations, suppressed endothelium-dependent contractions and reduced ROS production and expressions of NOX-2, NOX-4 and p67(phox) in arterial rings from SHR. Rb3 treatment also normalized angiotensin II (Ang II)-stimulated elevation in ROS and expression of NOX-2 and NOX-4 in arterial rings from WKY rats [4].
M.Wt | 1079.27 |
---|---|
Formula | C53H90O22 |
CAS No. | 68406-26-8 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : 20-((6-o-alpha-l-arabinopyranosyl-beta-d-glucopyranosyl)oxy)-12beta-hydroxydammar-24-en-3beta-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside;
Ginsenoside Rb2 is a 20(S)-protopanaxadiol glycoside extracted from ginseng, shows potent antioxidant and anticancer biological activities.
Weight | Price | Stock |
---|---|---|
20mg | 52.80$ | In Stock |
50mg | 119.80$ | In Stock |
100mg | 224.80$ | In Stock |
>500mg | Get quote | In Stock |
How to purchase?
IC50 Value & Target:
In Vitro: Treatment of 0.1 to 10μM Rb2 promoted the proliferation of MC3T3-E1 cells, improved alkaline phosphatase (ALP) expression, elevated calcium mineralization and mRNA expressions of Alp, Col1a1, osteocalcin (Ocn) and osteopontin (Opn) against oxidative damage induced by H2O2. Importantly, Rb2 reduced the expression levels of receptor activator of nuclear factor kappa-B ligand (RANKL) and IL-6 and inhibited the H2O2-induced production of ROS [1]. Ginsenoside-Rb2 showed the highest protective activity, although other dammarane-type and oleanolic acid-type ginsenosides also induced a significant protection against HVJ [2]. Rb2 (3~30 μM), perfused into an adrenal vein for 90 min, inhibited ACh (5.32 mM)-evoked CA secretory response in a dose- and time-dependent fashion. Rb2 (10 μM) also time-dependently inhibited the CA secretion evoked by DMPP (100 μM, a selective neuronal nicotinic receptor agonist) and high K(+) (56 mM, a direct membrane depolarizer) [3].
In Vivo: Multiple administrations of ginsenoside-Rb2 after the intravenous inoculation of B16-BL6 melanoma cells resulted in a significant inhibition of lung metastasis as compared with the untreated control [1].
M.Wt | 1079.27 |
---|---|
Formula | C53H90O22 |
CAS No. | 11021-13-9 |
Solvent & Solubility | 10 mM in water |
Storage | 2-8ºC & Sealed storage |
Alias : (3beta,12beta)-20-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Rb1 is part of a class of steroid glycosides; may have properties that inhibit or prevent the growth of tumors.
Weight | Price | Stock |
---|---|---|
20mg | 14.80$ | In Stock |
50mg | 35.80$ | In Stock |
100mg | 65.80$ | In Stock |
>500mg | Get quote | In Stock |
How to purchase?
IC50 Value & Target:
In Vitro: Rb1 inhibited melanogenesis in α-melanocyte-stimulating hormone (α-MSH) -stimulated B16 cells in a dose-dependent manner, which collectively indicated that Rb1 may have skin-whitening effects and may be formulated into skin-whitening products for skin care [1].
In Vivo: Application of 0.56mg of ginsenoside Rb1 resulted in significant decrement of scar elevation index, in comparison with control and lower dosage groups, furthermore achieved broader and randomly arranged collagen fibers resembling findings in normal dermis. Ginsenoside Rb1 concentration inversely correlated with the mRNA expression and immunohistochemical reactivity of scar related factors; MMP2, TIMP1, α- SMA, and TGF-β1 [2]. Ginsenoside Rb1 treatment...
M.Wt | 1109.29 |
---|---|
Formula | C54H92O23 |
CAS No. | 41753-43-9 |
Solvent & Solubility | Soluble in water (partly), methanol (9.8-10.2 mg/ml), and ethanol. |
Storage | 2-8ºC & Sealed storage |
Alias : (3beta,12beta)-12-hydroxy-20-((o-beta-d-xylopyranosyl-(1→3)-o-beta-d-glucopyranosyl-(1→6)-beta-d-glucopyranosyl)oxy)dammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Ra3 is extracted from roots and rhizomes of Panax ginseng, shows potent antioxidant biological activity.
Weight | Price | Stock |
---|---|---|
5mg | 586.80$ | In Stock |
10mg | 1120.80$ | In Stock |
20mg | 2170.80$ | In Stock |
50mg | 4741.80$ | In Stock |
>200mg | Get quote | In Stock |
How to purchase?
IC50 Value & Target:
In Vitro: Plasma 20(S)-protopanaxadiol and 20(S)-protopanaxatriol could be used as pharmacokinetic markers to reflect the subject's microbial activities, as well as the timely-changes and interindividual differences in plasma levels of their respective oxidized metabolites. [2].
In Vivo: After ingestion of Sanchi extract, ginsenosides Ra3, Rb1, Rd, Rg1, F1, Rh1, and notoginsenoside R1 were measured in plasma samples. Deglycosylated metabolites Compound-K, protopanaxadiol, and protopanaxatriol were also detected in plasma. Notably, several metabolites of protopanaxadiol and protopanaxatriol were found in human plasma and characterized, the plasma concentrations of which were significantly higher than those of the circulating ginsenosides. Conclusion: Although the ginsenoside aglycones protopanaxadiol and protopanaxatriol were not contained in the test Sanqi extract, their oxidized metabolites represented a class of major circulating compounds after ingestion of the herbal extract to humans. [1]. The PK profiles of the Sanqi ginsenosides in humans were comparable to those found in rats. Slight interspecies differences could have been due to humans being relatively poor biliary excretors compared with rats.[3].
M.Wt | 1241.41 |
---|---|
Formula | C59H100O27 |
CAS No. | 90985-77-6 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : (3beta,12beta)-12-hydroxy-20-((o-beta-d-xylopyranosyl-(1→2)-o-alpha-l-arabinofuranosyl-(1→6)-beta-d-glucopyranosyl)oxy)dammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Ra2 is extracted from roots and rhizomes of Panax ginseng.
Weight | Price | Stock |
---|---|---|
10mg | 326.20$ | In Stock |
20mg | 618.80$ | In Stock |
50mg | 1418.20$ | In Stock |
100mg | 2538.20$ | In Stock |
>300mg | Get quote | In Stock |
Leave message How to purchase?
IC50 Value & Target:
In Vitro: Have no relevant experimental datas.
In Vivo: Have no relevant experimental datas.
M.Wt | 1211.38 |
---|---|
Formula | C58H98O26 |
CAS No. | 83459-42-1 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : (3beta,12beta)-12-hydroxy-20-((o-beta-d-xylopyranosyl-(1→4)-o-alpha-l-arabinopyranosyl-(1→6)-beta-d-glucopyranosyl)oxy)dammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Ra1 is extracted from roots and rhizomes of Panax ginseng, shows inhibitory effects on protein tyrosine kinase.
Weight | Price | Stock |
---|---|---|
10mg | 362.80$ | In Stock |
20mg | 676.80$ | In Stock |
50mg | 1554.80$ | In Stock |
100mg | 2762.80$ | In Stock |
>300mg | Get quote | In Stock |
Leave message How to purchase?
IC50 Value & Target:
In Vitro: Ra1 and Ro showed significant inhibitory effects on PTK activation induced by H/R. Dose-response experiments revealed that ginsenoside-Rb1 was the most active compound and it completely blocked PTK activation at a wide range of concentrations. Most protopanaxadiol-type ginsenosides and some protopanaxatriol type saponins also showed significant effects on PTK activation.[1].
In Vivo: Have no relevant experimental datas.
M.Wt | 1211.38 |
---|---|
Formula | C58H98O26 |
CAS No. | 83459-41-0 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : Chikusetsusaponin 5; Chikusetsusaponin V; Polysciasaponin P3; (3beta)-28-(beta-d-glucopyranosyloxy)-28-oxoolean-12-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranosiduronic acid
Ginsenoside Ro, the predominant ginsenoside in the rhizome, is reported to have anti-inflammtory, anti-hepatitic activities, and showed inhibitory activity against 5αR with IC(50) value of 259.4 μm.
Weight | Price | Stock |
---|---|---|
20mg | 160.80$ | In Stock |
50mg | 375.80$ | In Stock |
100mg | 705.80$ | In Stock |
>500mg | Get quote | In Stock |
Leave message How to purchase?
IC50 Value & Target: 259.4 μm (for 5α-reductase )
In Vitro: Ginsenoside Ro exhibited suppressive activities on reactive oxygen species and matrix metalloproteinase-2 elevation in UV-B-irradiated fibroblasts. Ginsenoside Ro could overcome the reduction of the total glutathione contents in UV-B-irradiated fibroblasts. In IL-1β-induced rat chondrocytes, ginsenoside Ro exerted anti-apoptosis and anti-inflammation. Ro could improve IL-1β-induced chondrocytes viability. Ginsenoside Ro could suppress IL-1β-induced apoptosis by inhibiting levels of Bax and Bad, decreasing p53 phosphorylation and promoting the expression of Bcl-xL and PCNA. Ginsenoside Ro inhibited caspase 3 activity. IL-1β-induced inflammation and matrix degration were also alleviated by Ginsenoside Ro with down-regulating the expression of MMP 3, MMP 9 and COX-2. Moreover, ginsenoside Ro inhibited NF-κB p65 phosphorylation induced by IL-1β [2].
In Vivo: Topical administration of ginsenoside Ro (0.2 mg/mouse) to shaved skin inhibited hair re-growth suppression after shaving in the testosterone-treated C57BL/6 mice. Ginsenoside Ro showed inhibitory activity against 5αR with IC(50) value of 259.4 μm [3].
M.Wt | 957.11 |
---|---|
Formula | C48H76O19 |
CAS No. | 34367-04-9 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |